Connect with us

National

HISTORIC: Senate approves ‘Don’t Ask’ repeal

Congress wraps up legislative action on ending gay ban

Published

on

Sen. Harry Reid, along with other Democrats, voted for cloture on “Don’t Ask, Don’t Tell” legislation (Blade photo by Michael Key).

In a historic action, the U.S. Senate on Saturday passed legislation that would end the 17-year-old law prohibiting open gays from serving in the U.S. military.

Early in the day, the Senate voted 63-33 to invoke cloture on the legislation that would end “Don’t Ask, Don’t Tell” to move it to the floor. Later in the afternoon, the chamer approved the legislation by a vote of 65-31, effectively sending the measure to President Obama’s desk.

Clearing the 60-vote threshold needed to invoke cloture was the last significant hurdle for the bill on its path to passage and enactment into law.

For the cloture vote, six Republicans voted in the affirmative. They include Sen. Susan Collins (R-Maine), an original co-sponsor of the bill, as well as Sens. Olympia Snowe (R-Maine), Scott Brown (R-Mass) and Lisa Murkowski (R-Alaska). Each had indicated prior to the vote that they support the bill when it came to the floor.

Additional GOP  support for the legislation came from Sens. Mark Kirk (R-Ill.) and George Voinovich (R-Ohio). Three Republicans didn’t vote: Sens. Jim Bunning (R-Ky.), Judd Gregg (R-N.H.) and Orrin Hatch (R-Utah).

Following the cloture vote, Voinovich told reporters he voted in the affirmative because he believes the U.S. military should accept Americans who are qualified to serve.

“If people are not qualified to be in service because of their sexual orientation, then we ought to say, ‘You can’t get in,'” he said. “But if we know that they are qualified, then we ought not to have them lying [about] who they are [under] ‘Don’t Ask, Don’t Tell.’ It just is inconsistent with common sense.”

Sen. Joseph Lieberman (I-Conn.), the sponsor of the repeal legislation, told the Washington Blade following the vote that he wasn’t suprised by Kirk or Voinovich’s votes because they privately assured him they would vote in the affirmative earlier in the week.

“For their own reasons, they didn’t want to announce it, but they were true to their word — God bless them,” Lieberman said. “So, six Republicans was great.”

Lieberman praised the bipartisan nature with which the Senate passed “Don’t Ask, Don’t Tell” in a conversation with reporters following the vote.

“There’s been a lot of difficult times in the last couple years because it’s so partisan to get anything done.,” Lieberman said. “Here we are coming together — and it was bipartisan. We wouldn’t have done it without the Republicans and we got something really good passed, so I feel good about it.”

For the vote for final passage, two Republicans switched their “no” votes on cloture to “yes”: Sens. Richard Burr (R-N.C.) and John Ensign (R-Nev.).

On the Democratic side, all members who were present voted in favor of cloture and final passage, but Sen. Joe Manchin (D-W.Va.) didn’t vote at either time.

Earlier this month, Manchin voted against the motion to proceed on major defense legislation containing “Don’t Ask, Don’t Tell” repeal language. His office didn’t immediately respond to Blade’s request to comment on why he was absent.

Gay rights supporters were concerned that Sen. Kent Conrad (D-N.D.) would vote “no,” but he voted in the affirmative both for cloture and final passage along with nearly all of his Democratic colleagues.

The Senate invoked cloture to proceed with the “Don’t Ask, Don’t Tell” legislation after a vote failed on moving forward with the DREAM Act, an immigration-related bill, 55-41.

Joe Solmonese, president of the Human Rights Campaign, said the cloture vote shows that Congress has “recognized that all men and women have the right to openly serve their country.”

Solmonese also noted that the Senate was able to move “Don’t Ask, Don’t Tell” legislation past its most significant hurdle after many observers believed efforts to pass repeal this year were dead.

“Plenty of people had already planned the funeral for this legislation,” Solmonese said. “Today, we pulled out a victory from what was almost certain defeat just a few days ago.”

Alex Nicholson, executive director of Servicemembers United, called the vote a “historic step forward for this country” and said it “will very likely be a life-changing moment for gay and lesbian troops.”

“While we still have a long road ahead, including a final passage vote, the certification process, and a yet-to-be-determined implementation period, those who defend our freedom while living in fear for their careers will finally breathe a sigh of relief tonight, and those who have fallen victim to this policy in years past will finally begin to see true closure and redemption on the horizon,” Nicholson said.

The U.S. House earlier this week approved identical legislation, so when the Senate votes to approve final passage of the bill, the bill will head to President Obama’s desk.

Following the cloture vote, Lt. Col Victor Fehrenbach, an Air Force pilot who’s facing discharge under “Don’t Ask, Don’t Tell,” told the Washington Blade he was “overwhelmed” that the Senate finally took action to end the military’s gay ban.

“I didn’t think it was going to happen to be honest with you — at least not for a few years,” Fehrenbach said. “As soon as I heard my senator vote — Sen. Voinovich — I knew that we were over the 61 mark and I was pretty emotional over a while there.”

Fehrenbach said he felt “overwhelming happiness” not just for himself but for the estimated 66,000 other gay people serving in the armed forces.

“I’ll still be in limbo, but I know now that I’ll be able to retire in October, so it’s a great feeling to know that this is coming to end — that there is a light at the end of the tunnel,” he said.

In a statement White House Press Secretary Robert Gates confirmed Obama intends to sign the legislation passed by the Senate into law.

“As the president has long said, ending ‘Don’t Ask, Don’t Tell,’ and allowing gay men and women to serve openly in the military, will strengthen our national security while upholding the basic equality on which this nation was founded,” Gibbs said. “The president looks forward to signing the bill into law.”

Gates called on to stop discharges

Now that legislative action on “Don’t Ask, Don’t Tell” is complete, increased attention is being placed on the Obama administration to issue an executive order barring further discharges until repeal is implemented.

Aubrey Sarvis, executive director of the Servicemembers Legal Defense Network, renewed his call for such an order during a news conference after the Senate invoked cloture on the legislation.

“During this limbo interim period, I respectfully call upon the secretary of defense — Secretary Gates — to use his existing authority to suspend all investigations and all discharges until the law is finally repealed,” Sarvis said.

The SLDN head said such a move is necessary from the Obama administration because the legislation still has to make its way to the Obama desk, the president and Pentagon leaders have to certify that repeal can happen and a 60-day waiting process has to take place.

Gay advocates — including Human Rights Campaign President Joe Solmonese — have been calling on President Obama to issue an order stopping discharges since the start of his administration.

At the news conference, Senate Majority Leader Harry Reid (D-Nev.) said he supports the idea of Gates issues an order to suspend discharges as the repeal legislation heads to the president’s desk.

Senate Armed Services Committtee Chair Carl Levin (D-Mich.) also told reporters following the conference he favors such a move from Gates.

In a statement, Defense Secretary Robert Gates said he wouldn’t issue such an order until he can certify that the U.S. military is ready for repeal.

“It is therefore important that our men and women in uniform understand that while today’s historic vote means that this policy will change, the implementation and certification process will take an additional period of time,” Gates said. “In the meantime, the current law and policy will remain in effect.”

A White House spokesperson didn’t respond on short notice to comment on the matter.

In October, Gates issued new guidance limiting the discharge authority for “Don’t Ask, Don’t Tell” to the militaries service secretaries in cooperation with the Pentagon’s general counsel and the under secretary of defense for personnel and readiness. According to the Associated Press, since that time, no discharges have taken place under the law.

Senators debate gay ban

Prior to the votes, senators on the floor spoke out passionately both in favor and against repeal of “Don’t Ask, Don’t Tell.”

Opponents of repeal said the timing wasn’t right for Congress to act on ending the law as the U.S. military engaged in operations overseas, while those advocating for an end to “Don’t Ask, Don’t Tell” said all able bodies — including gay service members — were needed to confront these threats.

Levin disputed the assertions of those who would call supporting “Don’t Ask, Don’t Tell” repeal a partisan vote and noted polls showing an “overwhelming majority” supports ending the law.

“I’m not here for partisan reasons,” Levin said. “I’m here because men and women wearing the uniform of the United States who are gay and lesbian have died for this country, because gay and lesbian men and women wearing the uniform of this country have their lives on the line right now in Afghanistan and Iraq and other places for this country.”

Levin also noted that a provision in the legislation mandates that repeal won’t take effect until the president, defense secretary and the chair of the Joint Chiefs of Staff certify the U.S. military is ready for repeal.

“Secretary Gates has assured everybody that he is not going to certify that the military is ready for repeal until he is satisfied with the advice of the service chiefs that we had, in fact, mitigated, if not eliminated to the extent possible, risks to combat readiness to unit cohesion and effectiveness,” Levin said.

But Sen. John McCain (R-Ariz.) said while repeal of “Don’t Ask, Don’t Tell” may lead to “high-fives all over the liberal bastions of America,” an end of the statute would threaten military recruitment and battle effectiveness.

“We are doing great damage, and could possibly, and probably — as the commandant of the Marine Corps said, and I’ve been told literally thousands of members of the military — harm the battle effectiveness, which is so vital to the support, to the survival of our young men and women in the military,” McCain said.

Sen. Lindsey Graham (R-S.C.), an opponent of repeal, invoked Marine Corps Commandant Gen. James Amos suggestion earlier this week that “Don’t Ask, Don’t Tell” repeal could be a “distraction” that would lead to the loss of Marines’ lives on the battlefield.

“Some will say this is a civil rights issue of time,” Graham said. “The day has come.  We need to move forward as a nation. The Marine Corps does not have that view.”

Graham railed against the decision of Senate leadership to prohibit senators from offering any amendments to the legislation.

“To those senators who will take the floor today and announce this as a major advancement of civil rights in America, please let it be said that you’re doing it in a fashion that those who have a different view cannot offer one amendment,” Graham said. “Does that matter? Apparently not.”

Reid had “filled the tree” prior to the vote to prohibit any senators from offering amendments to the legislation. Amending the bill would have sent the bill back to the House and could have killed the measure.

Advertisement
FUND LGBTQ JOURNALISM
SIGN UP FOR E-BLAST

Israel

A Wider Bridge to close

LGBTQ Jewish group said financial challenges prompted decision

Published

on

U.S. Rep. Debbie Wasserman Schultz (D-Fla.) speaks at the Capital Jewish Museum in D.C. on June 5, 2025, after A Wider Bridge honored her at its Pride event. A Wider Bridge has announced it will shut down. (Washington Blade photo by Michael K. Lavers)

A Wider Bridge on Friday announced it will shut down at the end of the month.

The group that “mobilizes the LGBTQ community to fight antisemitism and support Israel and its LGBTQ community” in a letter to supporters said financial challenges prompted the decision.

“After 15 years of building bridges between LGBTQ communities in North America and Israel, A Wider Bridge has made the difficult decision to wind down operations as of Dec. 31, 2025,” it reads.

“This decision comes after challenging financial realities despite our best efforts to secure sustainable funding. We deeply appreciate our supporters and partners who made this work possible.”

Arthur Slepian founded A Wider Bridge in 2010.

The organization in 2016 organized a reception at the National LGBTQ Task Force’s Creating Change Conference in Chicago that was to have featured to Israeli activists. More than 200 people who protested against A Wider Bridge forced the event’s cancellation.

A Wider Bridge in 2024 urged the Capital Pride Alliance and other Pride organizers to ensure Jewish people can safely participate in their events in response to an increase in antisemitic attacks after Hamas militants attacked Israel on Oct. 7, 2023.  

The Jewish Telegraphic Agency reported authorities in Vermont late last year charged Ethan Felson, who was A Wider Bridge’s then-executive director, with lewd and lascivious conduct after alleged sexual misconduct against a museum employee. Rabbi Denise Eger succeeded Felson as A Wider Bridge’s interim executive director.

A Wider Bridge in June honored U.S. Rep. Debbie Wasserman Schultz (D-Fla.) at its Pride event that took place at the Capital Jewish Museum in D.C. The event took place 15 days after a gunman killed two Israeli Embassy employees — Yaron Lischinsky and Sarah Milgrim — as they were leaving an event at the museum.

“Though we are winding down, this is not a time to back down. We recognize the deep importance of our mission and work amid attacks on Jewish people and LGBTQ people – and LGBTQ Jews at the intersection,” said A Wider Bridge in its letter. “Our board members remain committed to showing up in their individual capacities to represent queer Jews across diverse spaces — and we know our partners and supporters will continue to do the same.”

Editor’s note: Washington Blade International News Editor Michael K. Lavers traveled to Israel and Palestine with A Wider Bridge in 2016.

Continue Reading

The White House

‘Trump Rx’ plan includes sharp cuts to HIV drug prices

President made announcement on Friday

Published

on

President Donald Trump during his meeting on lowering drug prices through TrumpRx. (Washington Blade photo by Joe Reberkenny)

President Donald Trump met with leaders from some of the world’s largest pharmaceutical companies at the White House on Friday to announce his new “Trump Rx” plan and outline efforts to reduce medication costs for Americans.

During the roughly 47-minute meeting in the Roosevelt Room, Trump detailed his administration’s efforts to cut prescription drug prices and make medications more affordable for U.S. patients.

“Starting next year, American drug prices will come down fast, furious, and will soon be among the lowest in the developed world,” Trump said during the meeting. “For decades, Americans have been forced to pay the highest prices in the world for prescription drugs by far … We will get the lowest price of anyone in the world.”

Trump signed an executive order in May directing his administration “to do everything in its power to slash prescription drug prices for Americans while getting other countries to pay more.”

“This represents the greatest victory for patient affordability in the history of American health care, by far, and every single American will benefit,” he added.

Several pharmaceutical executives stood behind the president during the announcement, including Sanofi CEO Paul Hudson, Novartis CEO Vas Narasimhan, Genentech CEO Ashley Magargee, Boehringer Ingelheim (USA) CEO Jean-Michel Boers, Gilead Sciences CEO Dan O’Day, Bristol Myers Squibb General Counsel Cari Gallman, GSK CEO Emma Walmsley, Merck CEO Robert Davis, and Amgen Executive Vice President Peter Griffith.

Also in attendance were Health and Human Services Secretary Robert F. Kennedy Jr., Commerce Secretary Howard Lutnick, Centers for Medicare and Medicaid Services Administrator Mehmet Oz, and Food and Drug Administration Commissioner Marty Makary.

Under the Trump Rx plan, the administration outlined a series of proposed drug price changes across multiple companies and therapeutic areas. Among them were reductions for Amgen’s cholesterol-lowering drug repatha from $573 to $239; Bristol Myers Squibb’s HIV medication reyataz from $1,449 to $217; Boehringer Ingelheim’s type 2 diabetes medication jentadueto from $525 to $55; Genentech’s flu medication xofluza from $168 to $50; and Gilead Sciences’ hepatitis C medication epclusa from $24,920 to $2,425.

Additional reductions included several GSK inhalers — such as the asthma inhaler advair diskus 500/50, from $265 to $89 — Merck’s diabetes medication januvia from $330 to $100, Novartis’ multiple sclerosis medication mayzent from $9,987 to $1,137, and Sanofi’s blood thinner plavix from $756 to $16. Sanofi insulin products would also be capped at $35 per month’s supply.

These prices, however, would only be available to patients who purchase medications directly through TrumpRx. According to the program’s website, TrumpRx “connects patients directly with the best prices, increasing transparency, and cutting out costly third-party markups.”

Kennedy spoke after Trump, thanking the president for efforts to lower pharmaceutical costs in the U.S., where evidence has shown that drug prices — including both brand-name and generic medications — are nearly 2.78 times higher than prices in comparable countries. According to the Pharmaceutical Research and Manufacturers of America, roughly half of every dollar spent on brand-name drugs goes to entities that play no role in their research, development, or manufacturing.

“This is affordability in action,” Kennedy said. “We are reversing that trend and making sure that Americans can afford to get the life-saving solutions.”

Gilead CEO Dan O’Day also spoke about how the restructuring of drug costs under TrumpRx, combined with emerging technologies, could help reduce HIV transmission — a virus that, if untreated, can progress to AIDS. The LGBTQ community remains disproportionately affected by HIV.

“Thank you, Mr. President — you and the administration,” O’Day said. “I think this objective of achieving the commitment to affordability and future innovation is extraordinary … We just recently launched a new medicine that’s only given twice a year to prevent HIV, and we’re working with Secretary Kennedy and his entire team, as well as the State Department, as a part of your strategy to support ending the epidemic during your term.

“I’ve never been more optimistic about the innovation that exists across these companies and the impact this could have on America’s health and economy,” he added.

Trump interjected, asking, “And that’s working well with HIV?”

“Yes,” O’Day replied.

“It’s a big event,” Trump said.

“It literally prevents HIV almost 100 percent given twice a year,” O’Day responded.

A similar anti-HIV medication is currently prescribed more than injectable form mentioned by O’Day. PrEP, is a medication regimen proven to significantly reduce HIV infection rates for people at high risk. Without insurance, brand-name Truvada can cost roughly $2,000 per month, while a generic version costs about $60 per month.

Even when medication prices are reduced, PrEP access carries additional costs, including clinic and laboratory fees, office visits, required HIV and sexually transmitted infection testing, adherence services and counseling, and outreach to potentially eligible patients and providers.

According to a 2022 study, the annual total cost per person for PrEP — including medication and required clinical and laboratory monitoring — is approximately $12,000 to $13,000 per year.

The TrumpRx federal platform website is now live at TrumpRx.gov, but the program is not slated to begin offering reduced drug prices until January.

Continue Reading

The White House

EXCLUSIVE: Democracy Forward files FOIA lawsuit after HHS deadnames Rachel Levine

Trans former assistant health secretary’s name changed on official portrait

Published

on

Adm. Rachel Levine (Washington Blade photo by Michael Key)

Democracy Forward, a national legal organization that works to advance democracy and social progress through litigation, policy and public education, and regulatory engagement, filed a lawsuit Friday in federal court seeking to compel the U.S. Department of Health and Human Services to release information related to the alteration of former Assistant Secretary for Health Adm. Rachel Levine’s official portrait caption.

The lawsuit comes in response to the slow pace of HHS’s handling of multiple Freedom of Information Act requests — requests that federal law requires agencies to respond to within 20 working days. While responses can take longer due to backlogs, high request volumes, or the need for extensive searches or consultations, Democracy Forward says HHS has failed to provide any substantive response.

Democracy Forward’s four unanswered FOIA requests, and the subsequent lawsuit against HHS, come days after someone in the Trump-Vance administration changed Levine’s official portrait in the Hubert H. Humphrey Building to display her deadname — the name she used before transitioning and has not used since 2011.

According to Democracy Forward, HHS “refused to release any records related to its morally wrong and offensive effort to alter former Assistant Secretary for Health Admiral Rachel Levine’s official portrait caption.” Levine was the highest-ranking openly transgender government official in U.S. history and served as assistant secretary for health and as an admiral in the U.S. Public Health Service Commissioned Corps from 2021 to 2025.

Democracy Forward President Skye Perryman spoke about the need to hold the Trump-Vance administration accountable for every official action, especially those that harm some of the most targeted Americans, including trans people.

“The question every American should be asking remains: what is the Trump-Vance administration hiding? For an administration that touts its anti-transgender animus and behavior so publicly, its stonewalling and silence when it comes to the people’s right to see public records about who was behind this decision is deafening,” Perryman said.

“The government’s obligation of transparency doesn’t disappear because the information sought relates to a trailblazing former federal official who is transgender. It’s not complicated — the public is entitled to know who is making decisions — especially decisions that seek to alter facts and reality, erase the identity of a person, and affect the nation’s commitment to civil rights and human dignity.”

“HHS’s refusal to respond to these lawful requests raises more serious concerns about transparency and accountability,” Perryman added. “The public has every right to demand answers — to know who is behind this hateful act — and we are going to court to get them.”

The lawsuit also raises questions about whether the alteration violated federal accuracy and privacy requirements governing Levine’s name, and whether the agency improperly classified the change as an “excepted activity” during a lapse in appropriations. By failing to make any determination or produce any records, Democracy Forward argues, HHS has violated its obligations under federal law.

The case, Democracy Forward Foundation v. U.S. Department of Health and Human Services, was filed in the U.S. District Court for the District of Columbia. The legal team includes Anisha Hindocha, Daniel McGrath, and Robin Thurston.

The Washington Blade reached out to HHS, but has not received any comment.

The lawsuit and four FOIA requests are below:

Continue Reading

Popular